Literature DB >> 6628223

Extravasation: a hazard of intravenous therapy.

M E MacCara.   

Abstract

Tissue damage due to extravasation does not occur frequently, but the consequences can be severe. Certain factors are important in determining the likelihood of extravasation injury. These include the age, state of consciousness, and venous circulation of the patient and the type, location, and placement of the intravenous cannula. Extravasation injury is induced most frequently by drugs that have high osmolalities, vesicant properties, or the ability to induce ischemia. Treatment includes elevation of the extremity, application of heat or cold, and the administration of an appropriate antidote. Prevention of extravasation injury requires recognition of potentially hazardous drugs and good technique in administering drugs intravenously.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628223     DOI: 10.1177/106002808301701002

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  16 in total

Review 1.  [Antineoplastic drug-induced extravasation].

Authors:  Maike de Wit
Journal:  Med Klin (Munich)       Date:  2010-11

2.  Comparison of soft tissue effects of conventional ionic, low osmolar ionic and nonionic iodine containing contrast material in experimental animals.

Authors:  W H McAlister; J M Kissane
Journal:  Pediatr Radiol       Date:  1990

3.  A Case of Metronidazole Injection Infiltration Without Sequelae.

Authors:  Andrew M North; Justin M Yee
Journal:  Hosp Pharm       Date:  2017-08-04

4.  Gauze vs. plastic for peripheral intravenous dressings: testing a new technology.

Authors:  B Littenberg; L Thompson
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

5.  Severe extravasation injury: an avoidable iatrogenic disaster?

Authors:  D A Burd; G Santis; T M Milward
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

6.  Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.

Authors:  Ursula Pluschnig; Werner Haslik; Günther Bayer; Afschin Soleiman; Rupert Bartsch; Wolfgang Lamm; Günther G Steger; Christoph C Zielinski; Robert M Mader
Journal:  Support Care Cancer       Date:  2014-11-30       Impact factor: 3.603

7.  Mitoxantrone: an overview of safety and toxicity.

Authors:  L E Posner; G Dukart; J Goldberg; T Bernstein; K Cartwright
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 8.  [Extravasation of cytotoxic agents].

Authors:  Elisabeth Nogler-Semenitz; Ines Mader; Patrizia Fürst-Weger; Robert Terkola; Sabine Wassertheurer; Pietro Giovanoli; Robert M Mader
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

Review 9.  Model for the physics and physiology of fluid administration.

Authors:  J H Philip
Journal:  J Clin Monit       Date:  1989-04

10.  Outcomes and Management of Peripheral Intravenous Infiltration Injuries.

Authors:  Joseph T Gibian; Danny Zakria; Cooper March; Basil Schaheen; Brian C Drolet
Journal:  Hand (N Y)       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.